People: Rigel Pharmaceuticals Inc (RIGL.O)

RIGL.O on Consolidated Issue listed on NASDAQ Global Market

9.09USD
9 Feb 2010
Price Change (% chg)

$0.50 (+5.82%)
Prev Close
$8.59
Open
$8.62
Day's High
$9.10
Day's Low
$8.55
Volume
578,963
Avg. Vol
463,235
52-wk High
$14.75
52-wk Low
$4.19

view people for:

Payan, Donald 

Brief Biography

Donald G. Payan, M.D., one of the co-founders of Rigel Pharmaceuticals, has been a member of the company's Board of Directors since July 1996 and has served as Executive Vice President and Chief Scientific Officer since January 1997. In February 2008, Dr. Payan became Executive Vice President, President of Discovery and Research. From January 1997 to July 1998, he also served as Chief Operating Officer. From July 1996 to January 1997, Dr. Payan served as President and Chief Executive Officer. From December 1995 to May 1996, Dr. Payan was Vice President of AxyS Pharmaceuticals, Inc., a biopharmaceutical company. From September 1993 to December 1995, Dr. Payan was Executive Vice President and Chief Scientific Officer of Khepri Pharmaceuticals, Inc., which he founded and subsequently merged with AxyS Pharmaceuticals. Dr. Payan did his residency training in Medicine at the Massachusetts General Hospital, and is a former Professor at the University of California, San Francisco and member of The Howard Hughes Medical Institute.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
395,000 -- 1,249,950 1,644,950

Options Compensation

  Quantity Market Value
Excercisable 196,895 38,486.00
Unexercisable 214,022 10,885.00
Excercised 13,333 81,598.00
Name Fiscal Year Total
Gower, James 2,499,330
Maynard, Ryan 774,148
Rodriguez, Raul 1,609,880
Payan, Donald 1,644,950
Grossbard, Elliot 1,504,840
Vance, Dolly 389,869
As Of 30 Dec 2008
view people for: